Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,179,914 papers from all fields of science
Search
Sign In
Create Free Account
antigen 3008, Plasmodium chabaudi
Known as:
Ag3008 protein, Plasmodium chabaudi
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Protozoan Proteins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
IFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection
Ismail Sebina
,
K. James
,
+14 authors
A. Haque
PLoS Pathogens
2016
Corpus ID: 12747519
Parasite-specific antibodies protect against blood-stage Plasmodium infection. However, in malaria-endemic regions, it takes many…
Expand
2008
2008
Blockade of TNF receptor 1 reduces disease severity but increases parasite transmission during Plasmodium chabaudi chabaudi infection.
G. Long
,
B. Chan
,
J. Allen
,
A. Read
,
A. Graham
International Journal of Parasitology
2008
Corpus ID: 17334411
2003
2003
Induction of Specific T-Cell Responses, Opsonizing Antibodies, and Protection against Plasmodium chabaudi adami Infection in Mice Vaccinated with Genomic Expression Libraries Expressed in Targeted…
Adam Rainczuk
,
Adam Rainczuk
,
Tatiana Scorza
,
P. Smooker
,
Terry W. Spithill
Infection and Immunity
2003
Corpus ID: 10052590
ABSTRACT It has been proposed that a multivalent malaria vaccine is necessary to mimic the naturally acquired resistance to this…
Expand
2000
2000
CD4+ T Cells Acting Independently of Antibody Contribute to Protective Immunity to Plasmodium chabaudi Infection After Apical Membrane Antigen 1 Immunization1
Huji Xu
,
A. Hodder
,
Huara Yan
,
P. Crewther
,
R. Anders
,
M. Good
Journal of Immunology
2000
Corpus ID: 24708750
Apical membrane Ag 1 (AMA1) is a leading malaria vaccine candidate. Homologues of AMA1 can induce protection in mice and monkeys…
Expand
Highly Cited
1998
Highly Cited
1998
Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism.
H. L. Shear
,
Leonid Grinberg
,
+4 authors
Ronald L. Nagel
Blood
1998
Corpus ID: 3486912
Studies in vitro by Pasvol et al (Nature, 270:171, 1977) have indicated that the growth of Plasmodium falciparum in cells…
Expand
Highly Cited
1993
Highly Cited
1993
Altered response of CD4+ T cell subsets to Plasmodium chabaudi chabaudi in B cell-deficient mice.
T. von der Weid
,
J. Langhorne
International Immunology
1993
Corpus ID: 36973670
Mice depleted of B cells from birth by treatment with anti-mu antibodies can control but not clear an infection with the malaria…
Expand
Review
1989
Review
1989
The Response of CD4+ T Cells to Plasmodium chabaudi chabaudi
J. Langhorne
,
S. Meding
,
K. Eichmann
,
S. Gillard
Immunological Reviews
1989
Corpus ID: 36377616
We have studied the role of CD4+ T cells in the immune response to Plasmodium chabaudi chabaudi. From in vivo experiments in…
Expand
1989
1989
Molecular karyotyping of the rodent malarias Plasmodium chabaudi, Plasmodium berghei and Plasmodium vinckei.
M. Sheppard
,
J. Thompson
,
R. Anders
,
D. Kemp
,
A. Lew
Molecular and biochemical parasitology (Print)
1989
Corpus ID: 37005052
Highly Cited
1986
Highly Cited
1986
Antigen-specific, interleukin 2-propagated T lymphocytes confer resistance to a murine malarial parasite, Plasmodium chabaudi adami.
D. Brake
,
W. Weidanz
,
C. Long
Journal of Immunology
1986
Corpus ID: 623414
To explore cell-mediated immune mechanisms in host defense against malaria, we utilized a murine model system in which antibody…
Expand
1973
1973
A comparative study on the ultrastructure of Plasmodium sporozoites within the oöcyst and salivary glands, with particular reference to the incidence of the micropore.
R. Sinden
,
P. Garnham
Transactions of the Royal Society of Tropical…
1973
Corpus ID: 33743551
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE